IRMD Earnings & Financial Statements
IRadimed Corporation
$89.33
-$0.50(-0.56%)
57
Overall
45
Value
63
Tech
65
Quality
Market Cap
$1.15B
Volume
31.01K
52W Range
$71.34 - $107.90
Target Price
$118.00
IRMD earnings and financial statements: IRadimed Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
IRMD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $83.81M | $73.24M | $65.56M | $53.30M | $41.81M |
| Cost of revenue | $19.49M | $16.89M | $15.40M | $12.02M | $9.76M |
| Operating income | $26.15M | $21.96M | $20.04M | $15.63M | $9.82M |
| EBITDA | $29.53M | $25.09M | $22.50M | $16.30M | $11.22M |
| Net income | $22.48M | $19.23M | $17.19M | $12.83M | $9.33M |
| EPS (diluted) | $1.75 | $1.50 | $1.35 | $1.02 | $0.74 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $108.78M | $98.33M | $92.16M | $85.51M | $82.88M |
| Total liabilities | $14.16M | $11.51M | $20.74M | $11.84M | $10.71M |
| Shareholders’ equity | $94.62M | $86.82M | $71.42M | $73.67M | $72.17M |
| Cash and equivalents | $51.16M | $52.23M | $49.76M | $57.96M | $62.00M |
| Long-term debt | - | $2.0K | $1.62M | $1.91M | $2.21M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $24.95M | $25.62M | $13.47M | $10.04M | $11.26M |
| Capital expenditure | -$8.42M | -$8.82M | -$8.01M | -$1.87M | -$741.8K |
| Free cash flow | $16.53M | $16.81M | $5.46M | $8.17M | $10.52M |
| Dividends paid | $15.04M | $13.68M | $13.22M | $12.56M | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRMD | $89.33 | -0.6% | 31.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |